BRIDGEBIO PHARMA INC. - COMMON STOCK
24.78
12-11月-24 13:32:49
15 分の遅延
株式
-1.34
-5.13%
本日の幅
24.22 - 26.62
ISIN
N/A
ソース
NASDAQ
-
BridgeBio Pharma Reports First Quarter 2022 Financial Results and Business Update
05 5 2022 06:30:02 提供 Nasdaq GlobeNewswire
-
03 4 2022 07:36:00 提供 Nasdaq GlobeNewswire
-
11 3 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
08 3 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
24 2 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
27 1 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study
27 12 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 12 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
19 11 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing
18 11 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 6 2021 15:35:00 提供 Nasdaq GlobeNewswire
-
01 6 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
28 5 2021 13:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 5 2021 15:30:00 提供 Nasdaq GlobeNewswire
-
14 5 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma, Inc. Reports First Quarter 2021 Financial Results And Business Update
06 5 2021 06:30:01 提供 Nasdaq GlobeNewswire
-
13 4 2021 06:45:00 提供 Nasdaq GlobeNewswire
-
13 4 2021 06:42:00 提供 Nasdaq GlobeNewswire